Hip Fractures (ICD-10 72.01-72.2)MOVE-HIPNCT07556263
Mobility and Activity of Daily Living Outcomes After a Hip Fracture.
An observational study of Hip Fractures (ICD-10 72.01-72.2), run by JointResearch at 1 site in Netherlands.
Trial summary
Hip fractures in especially older adults cause severe clinical and functional impacts. Despite improved surgical care, one year mortality remains 14-30%, and fewer than half of the survivors regain their pre-fracture functional status. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hip Fractures (ICD-10 72.01-72.2)
- How many people
- 1,200 participants
- Where
- 1 siteNetherlands
- Study dates
- 1 Jan 2016to 31 Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will involve patients who have obtained a hip fracture between 01-01-2016 and 31-12-2025 and who were 18 years or older at the time of the injury. To be included in the initial dataset it is necessary for the patient to have a value for baseline (pre-fracture) ADL independence and/or mobility, and to have an outcome at three months for ADL independence and/or mobility.
Who may be able to join
- Patient has been treated for a hip fracture in OLVG hospital betweek 01-01-2016 and 31-12-2025
- Patient was 18 years or older at the time of the injury
Who cannot join
- The patient does not grant permission for the use of their data for studies
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
OLVG hospital
Amsterdam
Joint Research, +31 20 5992757, jointresearch@olvg.nl
About this study
Official title: Mobility and Activity of Daily Living Outcomes After a Hip Fracture: Variabeles for Expectation.
Hip fractures in especially older adults cause severe clinical and functional impacts. Despite improved surgical care, one year mortality remains 14-30%, and fewer than half of the survivors regain their pre-fracture functional status. After a hip fracture, patients are primarily concerned with what they will be able to do in daily life. Wihout accurate predictions of mobility and Activities of Daily Life (ADL) independence, it is difficult to set realistic expectations and make appropriate decisions regarding treatment and rehabilitation. While there have been advancements in developing predictive models for mortality following hip fractures, there is a notable gap in models focused on predicting functional recovery. This study aims to develop and validate a machine learning-based model that can predict mobility and ADL independence three months after obtaining a hip fracture.
- Conditions
- Hip Fractures (ICD-10 72.01-72.2)
- Medical subject headings
- Hip Fractures
What is being measured
The primary outcome is the main question the study is designed to answer.
"Estimated mobility 3 months, after obtaining a hip fracture" "Estimated ADL independence 3 months after obtaining a hip fracture"
For the outcome mobility participants get to know if they will be mobility independent (score 1-3 will get a 0) or mobility depenedent (score 4-5 will get a 0). for the outcome ADL independence patients get a score indicating whether ADL is maintained/better (1) and else if ADL is deteriorated (0).
Measured: ADL independence and mobility 3 months after a hip fracture
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Apr 2026
- Study start1 Jan 2016
- Primary completion31 Dec 2025
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip Fractures (ICD-10 72.01-72.2)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- JointResearch
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07556263
- Sponsor's protocol ID
- WO 26.020
- Acronym
- MOVE-HIP
- Status last verified
- Jun 2026
- First submitted
- 22 Apr 2026
- Last updated
- 4 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mobility and Activity of Daily Living Outcomes After a Hip Fracture: Variabeles for Expectation.
- ClinicalTrials.gov ID
- NCT07556263
- Acronym / sponsor ID
- MOVE-HIP / WO 26.020
- Conditions
- Hip Fractures (ICD-10 72.01-72.2)
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,200 participants (estimated)
- Lead sponsor
- JointResearchUniversity, hospital or other
- Study start
- 1 Jan 2016 (actual)
- Primary completion
- 31 Dec 2025 (actual)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 29 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hip fractures in especially older adults cause severe clinical and functional impacts. Despite improved surgical care, one year mortality remains 14-30%, and fewer than half of the survivors regain their pre-fracture functional status. After a hip fracture, patients are primarily concerned with what they will be able to do in daily life. Wihout accurate predictions of mobility and Activities of Daily Life (ADL) independence, it is difficult to set realistic expectations and make appropriate decisions regarding treatment and rehabilitation. While there have been advancements in developing predictive models for mortality following hip fractures, there is a notable gap in models focused on predicting functional recovery. This study aims to develop and validate a machine learning-based model that can predict mobility and ADL independence three months after obtaining a hip fracture.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will involve patients who have obtained a hip fracture between 01-01-2016 and 31-12-2025 and who were 18 years or older at the time of the injury. To be included in the initial dataset it is necessary for the patient to have a value for baseline (pre-fracture) ADL independence and/or mobility, and to have an outcome at three months for ADL independence and/or mobility.
Key inclusion criteria (2 listed)
- Patient has been treated for a hip fracture in OLVG hospital betweek 01-01-2016 and 31-12-2025
- Patient was 18 years or older at the time of the injury
Key exclusion criteria (1 listed)
- The patient does not grant permission for the use of their data for studies
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
"Estimated mobility 3 months, after obtaining a hip fracture" "Estimated ADL independence 3 months after obtaining a hip fracture"
Time frame: ADL independence and mobility 3 months after a hip fracture
For the outcome mobility participants get to know if they will be mobility independent (score 1-3 will get a 0) or mobility depenedent (score 4-5 will get a 0). for the outcome ADL independence patients get a score indicating whether ADL is maintained/better (1) and else if ADL is deteriorated (0).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2026.
Related trials for Hip Fractures (ICD-10 72.01-72.2)
Not yet recruitingPhase 4
Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture
Hip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia
Not yet recruitingObservational study
Improving Shared DECISion-making in oldEr Hip Fracture Patients Living With Frailty
Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Hip Fractures (ICD-10 72.01-72.2)
RecruitingObservational study
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
Hip Fractures (ICD-10 72.01-72.2), Osteoarthritis, Knee and Hip
Recruiting
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
Hip Fractures (ICD-10 72.01-72.2)
Not yet recruiting
Frailty Intervention in Postoperative Hip Fracture Inpatients
Hip Fractures (ICD-10 72.01-72.2), Frailty at Older Adults
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fractures (ICD-10 72.01-72.2), run by JointResearch at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
"Estimated mobility 3 months, after obtaining a hip fracture" "Estimated ADL independence 3 months after obtaining a hip fracture" (time frame: ADL independence and mobility 3 months after a hip fracture). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026.